Letter to the Editor: When Expertly Applied, ESMO-MCBS and ASCO Net Health Benefit Scores Usually Agree

Authors: Nathan I. Cherny MBBS, FRACP, FRCP, LLD 1 , 2 , 3 , Elisabeth G. E. de Vries MD, PhD 4 , 5 , 6 , 7 and Richard L. Schilsky MD 8 , 9
View More View Less
  • 1 Cancer Pain and Palliative Medicine Service
  • 2 Shaare Zedek Medical Center
  • 3 Jerusalem, Israel Email: mcbs@esmo.org
  • 4 Department of Medical Oncology
  • 5 University Medical Center Groningen
  • 6 University of Groningen
  • 7 Groningen, The Netherlands
  • 8 American Society of Clinical Oncology
  • 9 Alexandria, VA
Restricted access
  • 1.

    Nabhan C, Phillips EG Jr, Feinberg BA. Value in oncology: it is in the eyes of the beholder. J Natl Compr Canc Netw 2019;17:25.

  • 2.

    Evans WK, Cheung MC, Chan KK. Measuring value and benefit: a matter of perspective. Lancet Oncol 2017;18:839840.

  • 3.

    Cherny NI, de Vries EG, Dafni U, . Comparative assessment of clinical benefit using the ESMO-Magnitude of Clinical Benefit Scale version 1.1 and the ASCO Value Framework Net Health Benefit Score. J Clin Oncol 2018;37:336349.

    • Crossref
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 769 135 5
PDF Downloads 202 50 0
EPUB Downloads 0 0 0